Skip to content
Open access

Protein Age Bias in Target Degradation by PROTACs.

Sep 2026 · ACS Chemical Biology · Vol 21, pp. 2477-2487 · 0 citations · 39 references
Medicine

TL;DR

The findings reveal that PROTAC-mediated degradation is governed not only by target engagement and ternary complex formation but also by the dynamic balance between protein synthesis and degradation, providing a mechanistic framework for incomplete degradation and rebound kinetics.

Abstract

Targeted protein degradation (TPD) by PROteolysis TArgeting Chimeras (PROTACs) has emerged as a powerful chemical biology and therapeutic modality, yet many degraders exhibit incomplete target clearance and characteristic rebound kinetics despite continuous exposure. The mechanistic basis for this behavior remains poorly understood. Here, we uncover protein age as a previously unrecognized determinant of PROTAC efficacy. Using CG-SLENP, a chemical genetics strategy that selectively labels newly synthesized and pre-existing proteins within the same living cell, we directly resolve PROTAC-induced degradation of distinct intracellular protein populations. Applying this approach to the bromodomain protein BRD4, we show that two mechanistically and structurally distinct PROTACs, dBET6 and MZ-1, preferentially degrade pre-existing BRD4, while newly synthesized BRD4 is degraded substantially more slowly and incompletely. This age-dependent degradation bias is observed in live-cell imaging, across compound concentrations and time scales, and for both reporter and endogenous BRD4. BRD9-targeting PROTAC VZ185 exhibited similar degradation preference. These findings reveal that PROTAC-mediated degradation is governed not only by target engagement and ternary complex formation but also by the dynamic balance between protein synthesis and degradation. By identifying temporal proteostasis as a critical parameter in TPD, this work provides a mechanistic framework for incomplete degradation and rebound kinetics and therefore establishes protein maturation state as an important consideration for degrader design and evaluation.

Read PDF

Similar papers

Aug 2026

Integrative Proteomics and Ubiquitomics Reveal on-Targets and off-Targets of PROTAC dBET1.

This study demonstrates that integrating ubiquitomics provides a superior sensitivity layer for PROTAC safety assessment, capable of uncovering mechanism-based liabilities that escape conventional global proteomic screening.

Hongtao Wen, Hui Liu, Jinfang Liu et al. · 0 citations
Review Open access Aug 2026

PROTAC-Based Strategies in Neurodegenerative Diseases: Challenges and Perspectives

This review summarizes recent advances in chemical protein degradation strategies for neurodegenerative disorders and highlights potential future perspectives of multifunctional PROTACs for therapeutic development.

Pasquale Degennaro, Imane Ghafir El Idrissi, Rosa Purgatorio et al. · 0 citations
Open access Sep 2026

Fitness criteria for PROTACs as chemical probes: principles and applications.

Proteolysis-targeting chimeras (PROTACs) have emerged as a powerful class of chemical probes that degrade rather than inhibit target proteins, thus expanding the tools for studying protein function in cells. PROTACs trigger catalytic and sub-stoichiometric degradation of the target protein in contrast with stoichiometr...

M. Sturbaut, Alessio Ciulli · 0 citations
Review Sep 2026

BioPROTACs: a promising approach for targeted protein degradation.

The molecular mechanisms, recent advances, and emerging applications of bioPROTAC technology are summarized, the current technical challenges are evaluated, potential strategies to address these limitations are discussed, and future directions that may facilitate its clinical translation are highlighted.

Yu-Yang Li, Fu-Ru Zhang, Ren-Shuai Zhang et al. · 0 citations
Review Sep 2026

Expanding the E3 Ligase Landscape: From Small Molecule to Biological Targeted Protein Degradation.

This review summarizes the development of classical small-molecule E3 ligase ligands and highlights emerging biological recruitment strategies involving antibodies, nanobodies, aptamers, peptides, and engineered proteins that provide greater programmability and selectivity.

Xuan Zhao, Yu-Han Liu, Xu-Cong Teng · 0 citations
Sep 2026

Hsc70-Mediated Targeting Chimeras for Targeted Protein Degradation via Chaperone-Mediated Autophagy

Despite the remarkable success of proteolysis-targeting chimeras (PROTACs), challenges such as limited applicability to certain cytosolic proteins, potential resistance risks, and off-target effects remain. Novel degradation strategies harnessing the autophagy/lysosome pathway may broaden the scope of protein targets...

Chao Chen, Yi-Lun Zheng, Xiu-Yu Tao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.